NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding NRX Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 22 | 25 | +3 |
| Shares | 2.26M | 2.99M | +733.8K (+32.5%) |
| Value | $4.60M | $9.76M | +$5.16M (+112.1%) |
New holders (5)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 92,361 | $301.1K | 0.00% |
| Squarepoint Ops LLC | 42,202 | $137.6K | 0.00% |
| Group One Trading, L.P. | 3,108 | $10.1K | 0.00% |
| Raymond James Financial Inc | 2,571 | $8.38K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,156 | $3.77K | 0.00% |
Sold out (2)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| TownSquare Capital, LLC | 15,041 | $30.8K |
| FMR LLC | 37 | $76 |